(IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer) The Gamida Cell-Teva Joint Venture announced today that five prestigious cord blood transplantations centers in Spain, three in Barcelona and two in Valencia, have joined the ExCell study.
The trial is assessing the safety and efficacy of StemEx as a treatment for hematological malignancies, including leukemia and lymphoma, in a single arm, global, pivotal marketing authorization trial.
gamida cell5 Spanish centers join a study for a new leukemia and lymphoma t...EurekAlert! - Cancer Tue, 06/02/2009 - 22:00
|
